VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 455 filers reported holding VANECK VECTORS ETF TR in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $59,000 | -96.8% | 1,530 | -96.9% | 0.00% | -100.0% |
| Q2 2020 | $1,817,000 | -80.0% | 49,551 | -87.4% | 0.00% | -83.3% |
| Q1 2020 | $9,070,000 | +75.4% | 393,646 | +122.9% | 0.01% | +140.0% |
| Q4 2019 | $5,171,000 | -42.3% | 176,600 | -49.6% | 0.01% | -37.5% |
| Q2 2019 | $8,964,000 | +42.0% | 350,705 | +24.5% | 0.01% | +33.3% |
| Q1 2019 | $6,314,000 | -2.7% | 281,625 | -8.5% | 0.01% | -14.3% |
| Q4 2018 | $6,489,000 | +80.6% | 307,705 | +91.0% | 0.01% | +133.3% |
| Q2 2018 | $3,594,000 | -16.9% | 161,105 | -18.1% | 0.00% | -25.0% |
| Q1 2018 | $4,323,000 | -43.1% | 196,700 | -40.5% | 0.00% | -42.9% |
| Q3 2017 | $7,592,000 | +75.1% | 330,660 | +68.3% | 0.01% | +75.0% |
| Q2 2017 | $4,337,000 | -52.1% | 196,420 | -42.6% | 0.00% | -55.6% |
| Q3 2016 | $9,046,000 | -2.1% | 342,253 | +2.6% | 0.01% | -10.0% |
| Q2 2016 | $9,242,000 | – | 333,515 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |